Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:49 PM
Ignite Modification Date:
2025-12-24 @ 12:49 PM
NCT ID:
NCT00735761
Eligibility Criteria:
Inclusion Criteria:
* History of recurrent herpes labialis with at least two recurrences during the twelve months prior to the study.
* Stable HIV infection
* CD4+ T-cell count 100 to 500/mm3
Exclusion Criteria:
* Systemic treatment with other antiviral agent or corticosteroids within two weeks prior to and during the treatment period, except for antiretroviral treatment in HIV subjects
* Topical treatment with other antiviral agent or corticosteroids within in or around the oral area within two weeks prior to study drug administration
* Significant skin condition that occur in the area typically affected by herpes recurrences
* Nursing or pregnancy
* Concurrent cancer therapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00735761
Study Brief:
Protocol Section:
NCT00735761